The relative lack of cancer-associated inactivating TSC2 mutations may result from the increased nutrient sensitivity associated with TSC2 loss and the inability of cells with TSC2 mutations to reconcile the metabolic needs for anabolic growth with nutrient availability (71). Here, TSC2 is linked to cancer.